Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guidance and tools
Guidance and tools
Choosing investments Choosing accounts ISA calculator Retirement calculators
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks IPOs and placings
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Europe open: Shares up on rate cut bets; Merck tanks on MS trial failure
(Sharecast News) - European shares made a strong start on Wednesday as investors started to bet on interest rate cuts and shrugged off an unexpected slump in German factory orders, while Merck shares tanked after a multiple-sclerosis drug failed in late-stage trials. The pan-European Stoxx 600 index was up 0.36% in early deals at 469.27 with all major regional bourses higher.
"Yesterday was all about markets fretting that the Fed would not cut rates anytime soon. Today they are back to believing that they will. Having pushed US bond yields all the way from 3.3% up to 5% in recent months, 10-year US bonds have been fighting back in recent weeks, with yields now back down to 4.2%," said Steve Clayton, head of equity funds at Hargreaves Lansdown.
"We're in the phoney war stage of the economic cycle. The action last night was really all in the bond market, with stocks little changed on Wall Street. But Asian markets rebounded from yesterday's weakness leaving things pretty much where they were."
In economic news, German factory orders unexpectedly slumped in October, according to figures released on Wednesday by Destatis.
Orders fell by 3.7% on the month following an upwardly-revised 0.7% increase in September, coming in weaker than expectations for a 0.2% jump.
Destatis said much of the decline was due to the performance of the manufacture of machinery and equipment sector, where new orders tumbled 13.5%.
By contrast, there was a 20.2% rise in new orders in the manufacture of other transport equipment such as aircraft, ships, trains, etc. This was thanks to large-scale orders received in this sector.
On the equities front, Merck shares were down 18% after phase III trials of its promising evobrutinib drug failed to show the required efficacy for treatment of multiple-sclerosis.
Tobacco and nicotine giant British American Tobacco was in the red after scaling back its expectations for organic growth this year and unveiling a massive £25bn impairment charge.
Nokia slipped again, falling 6%, following news that U.S. telecom giant AT&T will partner with Ericsson on the rollout of a next-generation wireless network.
Holiday giant Tui was on the rise after bumper profits and a forecast 25% rise in operating earnings this year, while Hello Fresh and Delivery Hero also gained after being named the top picks of internet stocks by JP Morgan.
Reporting by Frank Prenesti for Sharecast.com
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity and Inclusion | Doing Business with Fidelity | Fidelity gender pay report | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Security | Statutory and Regulatory disclosures | Whistleblowing policy
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.